At the December 10th, 2019 Hidradenitis Suppurativa support group meeting of the Detroit chapter of Hope for HS, Josee Smith, BSc, and medical student at Wayne State University School of Medicine presented a summary and brief overview of topics and presentations from the 4th annual Symposium on Hidradenitis Suppurativa Advances, followed by Q&A from Angie Parks-Miller, Clinical Research Manager for Henry Ford Hospital and President of Hope for HS.

The summary includes information on the most common and important hidradenitis suppurativa comorbidities, research breakthroughs in the parthenogenesis of HS, possible future targets for treatment, clinical trial outcome measures, pain management, surgical techniques, lifestyle management, knowledge gaps, and patient testimonials.

While the playback is no longer live, any questions that could be answered in a future presentation may be sent to  Follow our public Facebook page and turn on notifications to be notified of future livestreams.  If ever possible, attendance at in-person meetings is the best way to have your questions answered as most of our chapters choose not to stream their presentations and any time limitations for online Q&A would not be an issue.

The 2019 Symposium on Hidradenitis Suppurativa Advances was open for full attendance by patients and caregivers for the first time.  It is our hope that the 2020 symposium, taking place in Montreal, will also be open for attendance by patients and their caregivers.  If you are interested in attending next year’s symposium, be sure to bookmark and check back for a date announcement.  The annual SHSA generally occurs over a weekend in October or November.